Opdivo plus AVD showed superior PFS and EFS compared to Adcetris plus AVD in patients with advanced Hodgkin lymphoma. The Opdivo regimen had a better side effect profile, with fewer severe side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback